Title:
【発明の名称】腎機能障害患者における燐酸塩過剰血症予防のための19-ノル-ビタミンD化合物の使用
Document Type and Number:
Japanese Patent JP3255926
Kind Code:
B2
Abstract:
The 19-nor-vitamin D analogs, and particularly 19-nor-1 alpha ,25-dihydroxyvitamin D2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone (PTH) production. The suppressive effect on PTH secretion of these 19-nor analogs without significant changes in serum calcium or serum phosphorus make them ideal tools for the treatment of secondary hyperparathyroidism in patients having kidney disorders.
Inventors:
Deluca, Hector Ef
Slatpolsky, Eduardo
Slatpolsky, Eduardo
Application Number:
JP50595697A
Publication Date:
February 12, 2002
Filing Date:
July 09, 1996
Export Citation:
Assignee:
WISCONSIN ALUMNI RESEARCH FOUNDATION
International Classes:
A61K31/59; A61K31/592; A61K31/593; A61P3/02; A61P13/02; A61P15/00; (IPC1-7): A61K31/59; A61K31/592; A61K31/593; A61P3/02
Domestic Patent References:
| JP3505330A |
Attorney, Agent or Firm:
Kazuo Shamoto (5 outside)
Previous Patent: INTERNAL STRESS MEASURING METHOD FOR THIN FILM SAMPLE
Next Patent: DEFORMATION MEASURING METHOD FOR POLYGON MIRROR
Next Patent: DEFORMATION MEASURING METHOD FOR POLYGON MIRROR